Potentiation and abolition of the increase in plasma renin activity seen after hypotensive drugs in rats.
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001949:Bretylium Compounds / Q000494:pharmacology; D003864:Depression, Chemical; D004357:Drug Synergism; D006145:Guanethidine / Q000494:pharmacology; D006830:Hydralazine / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011941:Receptors, Adrenergic / Q000187:drug effects; D012083:Renin / Q000097:blood*; D013268:Stimulation, Chemical
D000959:Antihypertensive Agents; D001949:Bretylium Compounds; D011941:Receptors, Adrenergic; D006830:Hydralazine; D011433:Propranolol; D012083:Renin; D007545:Isoproterenol; D010646:Phentolamine; D006145:Guanethidine